CANCER BUZZ

The gender gap in healthcare leadership is well documented. In the oncology discipline, the divide is even wider—according to a recent survey, less than half of academic medical oncology programs have a woman in a leadership position, and that number decreases further for radiation and surgical oncology programs.

On this episode of CANCER BUZZ, learn how the Livestrong Cancer Institutes and Dell Medical School at the University of Texas at Austin are reaching out to young women in high school to generate interest in oncology. Through leadership training, meetings with program leaders, and a week-long research project, the Summer Healthcare Experience (SHE) lays the groundwork for female mentorship and support at an early age. Guests:

• Kristen E. Wynn, Senior Administrative Program Coordinator, Livestrong Cancer Institutes
• Ximena Cruz and Korena Martinez, Summer Healthcare Experience participants

Related Content:

• ACCC 37th [Virtual] National Oncology Conference
• National Oncology Conference: Featured Speakers
• 2020 ACCC Innovator Award Winners
• Cancer Life reiMagined: The CaLM Model of Whole-Person Cancer Care
• Proportion of Women in Oncology Leadership Positions Remains Low, Cancer Therapy Advisor

The views and opinions expressed herein are those of the author(s)/faculty member(s) and do not reflect the official policy or position of their employer(s) or the Association of Community Cancer Centers.

For patients undergoing treatment with cancer immunotherapy, immune-related adverse events most often present on the skin and can be so severe that patients opt to discontinue treatment. On this episode of CANCER BUZZ, we look at dermatology's role in the cancer care continuum and how cancer teams can better integrate dermatology into the immunotherapy care process. Guest:

• Joshua Arbesman, MD, Dermatologist, Cleveland Clinic

Related Content:

• ACCC Immuno-Oncology Institute
• Supportive Oncodermatology
• Managing IO Toxicities: Three Keys to Success, by Sigrun Hallmeyer, MD
• Immunotherapy & Mental Health (podcast)
• The Immunotherapy Patient Perspective (podcast)

The views and opinions expressed herein are those of the author(s)/faculty member(s) and do not reflect the official policy or position of their employer(s) or the Association of Community Cancer Centers.

The coronavirus pandemic has forced adjustments to all aspects of healthcare. On this episode of CANCER BUZZ, we look at recent adaptations in oncology—and how some of these changes can actually make cancer care stronger moving forward. Guest: Randall A. Oyer, MD, Medical Director, Oncology Program, Penn Medicine Lancaster General Health; 2020-2021 ACCC President

Related Content:

• ACCC COVID-19 Resource Center
• Mini-Podcast: COVID-19 & Telemedicine
• Webcast: ASCO Survey on COVID-19 in Oncology (ASCO) Registry
• Mini-Podcast: Cancer Screening During COVID-19
• Beyond the Pandemic: A Long-Term View of Medical Environments
• Curated COVID-19 Resources for Financial Advocacy

This mini-podcast is supported by educational grants from AstraZeneca Pharmaceuticals, Merck & Co., Inc., and Pfizer Inc.

The views and opinions expressed herein are those of the author(s)/faculty member(s) and do not reflect the official policy or position of their employer(s) or the Association of Community Cancer Centers.

Diagnoses of the six most prevalent cancers have decreased sharply, according to recent reports—indicative of big changes to oncology during the pandemic. On this mini-podcast, we look at the latest data on the effects of COVID-19 on cancer practices and explore how you can adapt to changes in oncology business. Guest: Jennifer Webster, MS, Vice President of Analytics and Data Solutions, Integra Connect

Related Content:

• ACCC COVID-19 Resource Center
• Webcast: Risk Stratification for Cancer Patients During COVID-19
• Mini-Podcast: COVID-19 & Telemedicine
• Mini-Podcast: Cancer Screening During COVID-19
• The "New Normal": Seven Questions Program Leaders Are Asking About Care Amid COVID-19

This mini-podcast is supported by educational grants from AstraZeneca Pharmaceuticals, Merck & Co., Inc., and Pfizer Inc.

The views and opinions expressed herein are those of the author(s)/faculty member(s) and do not reflect the official policy or position of their employer(s) or the Association of Community Cancer Centers.

On this mini-podcast, learn how surgical oncology has been impacted by the coronavirus pandemic and how programs are adapting to fluctuations in staff availability and patient volume. Guest: Lawrence Wagman, MD, Surgical Oncologist, City of Hope Medical Center; Regional Medical Director, City of Hope, Inland Empire Program

Related Content:

• ACCC COVID-19 Resource Center
• Webcast: Risk Stratification for Cancer Patients During COVID-19
• Webcast: Optimizing Staffing Strategies Amid COVID-19
• Mini-Podcast: Cancer Screening During COVID-19
• Bringing Surgical Oncology Services On Board

This mini-podcast is supported by educational grants from AstraZeneca Pharmaceuticals, Merck & Co., Inc., and Pfizer Inc.

The views and opinions expressed herein are those of the author(s)/faculty member(s) and do not reflect the official policy or position of their employer(s) or the Association of Community Cancer Centers.

This year, the Centers for Medicare & Medicaid Services reported that of the top ten discarded drugs reimbursed by Medicare Part B in 2018, six were cancer medications, totaling 330 million dollars. On this episode of CANCER BUZZ, learn about the ways cancer programs are working to reduce drug waste and curb the rising cost of cancer care.

Guest: Anthony Boyd, PharmD, BCPS, Pharmacy Manager, Oncology, Cleveland Clinic

Related Content:

• ACCC Oncology Pharmacy Education Network
• Waste Not, Want Not
• UNC Combats Rising Drug Prices by Reducing Expensive Waste
• The Evolution of Oncology Pharmacy (podcast)
• Facilitating Access to Cancer Immunotherapies
• Part B Discarded Drug Units Report, Centers for Medicare & Medicaid Services

The views and opinions expressed herein are those of the author(s)/faculty member(s) and do not reflect the official policy or position of their employer(s) or the Association of Community Cancer Centers.

The effect of delayed cancer screenings due to COVID-19 has the potential to put tens of thousands of lives at risk. On this mini-podcast, learn how some cancer programs are finding creative ways to engage patients and adapt screening programs during these difficult times. Guest: Renea Duffin, MPA, Vice President of Cancer Support and Outreach, Mary Bird Perkins Cancer Center

Related Content:

• ACCC COVID-19 Resource Center
• Mini-Podcast: COVID-19 Testing Strategies
• Mini-Podcast: Drive-Thru COVID-19 Screening
• Genetic Cancer Screening and Testing in a Medically Underserved Community
• Crushing Cancer Through Prevention and Early Detection
• Taking Lung Cancer Screening on the Road

This mini-podcast is supported by educational grants from AstraZeneca Pharmaceuticals, Merck & Co., Inc., and Pfizer Inc.

The views and opinions expressed herein are those of the author(s)/faculty member(s) and do not reflect the official policy or position of their employer(s) or the Association of Community Cancer Centers.

When a person between the ages of 30 and 50 is diagnosed with cancer, they face unique personal challenges—and a care continuum that wasn't necessarily designed for them. On this episode of CANCER BUZZ, author and cancer survivor Laura Holmes Haddad shares how her battle with breast cancer changed her perception of the resources available to younger adults with cancer, and what cancer programs can do to meet their needs.

Guest: Laura Holmes Haddad, author, This Is Cancer: Everything You Need to Know, from the Waiting Room to the Bedroom

Related Content:

• Diagnosis in Prime Time
• Perspective on the "Modern Cancer Patient"
• Enabling Fertility Discussions with Young Adult Male Oncology Patients
• Cancer Care Considerations for Sexual and Gender Minority Patients
• This is Cancer: Everything You Need to Know, from the Waiting Room to the Bedroom

The views and opinions expressed herein are those of the author(s)/faculty member(s) and do not reflect the official policy or position of their employer(s) or the Association of Community Cancer Centers.

On this mini-podcast, ACCC President-Elect Krista Nelson shares how Providence Cancer Institute has made staff resiliency and morale a priority during the COVID-19 pandemic, and offers resources you can use at your program. Guest: Krista Nelson, MSW, LCSW, OSW-C, BCD, Program Manager of Quality & Research, Cancer Support Services & Compassion, Providence Cancer Institute; 2020-2021 ACCC President-Elect

Related Content:

• ACCC COVID-19 Resource Center
• Mini-Podcast: COVID-19 Self-Care
• CANCER BUZZ Episode 2, "Fostering Cancer Care Team Resiliency & Well-Being"
• Mini-Podcast: COVID-19 & Music Therapy
• An Oncologist's Prescription for Managing Fear
• Lessons Learned from Cancer Patients

This mini-podcast is supported by educational grants from AstraZeneca Pharmaceuticals, Merck & Co., Inc., and Pfizer Inc.

The views and opinions expressed herein are those of the author(s)/faculty member(s) and do not reflect the official policy or position of their employer(s) or the Association of Community Cancer Centers.

On this mini-podcast, learn about Ochsner Cancer Center's testing strategy for COVID-19 and how you can adapt their guidance when establishing your own testing protocols. Guest: Zoe Larned, MD, Chair, Hematology/Oncology and Director, Inpatient Hematology/Oncology, Ochsner Health System

Related Content:

• ACCC COVID-19 Resource Center
• Planning Your COVID-19 Testing Strategy (webcast)
• Mini-Podcast: Drive-Thru COVID-19 Screening
• Creating a Safe Workplace During COVID-19
• COVID-19 Infection Prevention Measures (webcast)

This mini-podcast is supported by educational grants from AstraZeneca Pharmaceuticals, Merck & Co., Inc., and Pfizer Inc.

The views and opinions expressed herein are those of the author(s)/faculty member(s) and do not reflect the official policy or position of their employer(s) or the Association of Community Cancer Centers.